Based on 9 analysts giving stock ratings to Beauty Health Co in the past month.
In the current month, SKIN has received 1 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. SKIN average Analyst price target in the last month is 15.667.
Based on analysts' estimates, SKIN EPS is projected to reach -0.401 in FY2026Q4, following reported EPS of -0.136 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.14, while Beauty Health CoSKIN's earnings per share (EPS) for the previous quarter was USD -0.41. EPS for the next quarter is expected at USD -0.40.